Tong Ren Tang Technologies Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tong Ren Tang Technologies Company Limited with three other
companies in this sector in CHINA :
Beijing Aosaikang Pharmaceutical Co Ltd
sales of 4.52 billion Chinese Renmimbi [US$679.38 million]
of which 100%
was Pharmaceutical manufacturing),
Shenzhen Salubris Pharmaceuticals Co Ltd
(4.47 billion Chinese Renmimbi [US$672.13 million]
of which 98%
was Pharmaceutical Manufacturing), and
Jiangsu Kanion Pharmaceutical Co., Ltd.
(4.57 billion Chinese Renmimbi [US$686.47 million]
of which 99%
was Domestic Sales of Industrial Enterprises).
Tong Ren Tang Technologies Company Limited reported sales of 4.48 billion Chinese Renmimbi (US$673.03 million)
December of 2019.
decrease of 11.5%
versus 2018, when the company's sales were 5.06 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 13.0% decline
in the Company, from 3.22 billion Chinese Renmimbi to 2.80 billion Chinese Renmimbi.
There were also decreases in sales in
Tong Ren Tang Chinese Medicine (down 1.7% to 1.26 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
All Other Segments (up 1.2% to 1.06 billion Chinese Renmimbi)